2 terminated, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Completed 1 |
Follow Rotator Cuff Tendinopathy: new trials by email Literature Review of Rotator Cuff Tendinopathy trials Research Report on Rotator Cuff Tendinopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy Secukinumab, Placebo - Rotator Cuff Tendinopathy | Phase 3 | Terminated | Novartis Pharmaceuticals | 33 | 2023-08-10 | 2026-03-24 |
| Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy Secukinumab, Placebo - Rotator Cuff Tendinopathy | Phase 3 | Terminated | Novartis Pharmaceuticals | 60 | 2023-08-02 | 2025-12-18 |
| Effect of Plasma Rich in Growth Factors in Rotator Cuff Tendinopathy Plasma rich in growth factors (PRGF), Celestone cronodose (Bethametasone) - Rotator Cuff Tendinopathy | Phase 3 | Completed | Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias | 84 | 2014-02-01 | 2018-12-20 |
Tendinopathy (1)
Muscular Diseases (1) · Musculoskeletal Diseases (1) · Tendon Injuries (1) · Wounds and Injuries (1)
secukinumab (2) · Intercellular Signaling Peptides and Proteins (1)
Novartis Pharmaceuticals (2) · Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias (1)
Spain (2) · United States (2) · Argentina (1) · Bulgaria (1) · Canada (1) · China (1) · Czechia (1) · Italy (1) · Malaysia (1) · Poland (1) · Portugal (1) · Thailand (1)